等待开盘 12-20 09:30:00 美东时间
-0.180
-1.99%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Canaccord Genuity analyst Brian McNamara maintains Hillman Solns (NASDAQ:HLMN) with a Buy and maintains $15 price target.
11-24 22:50
Full Year 2025 Guidance - UpdatedBased on year-to-date performance and its expectations for the remainder of the year, management is updating its guidance most recently provided on August 5, 2025 with Hillman's second
11-04 20:32
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
08-29 22:01
Stifel analyst W. Andrew Carter maintains Hillman Solns (NASDAQ:HLMN) with a Buy and raises the price target from $10.75 to $12.
08-29 21:09
Hillman Solutions (NASDAQ:HLMN) has announced a share repurchase program for up to $100 million of the company’s outstanding common stock. This marks the first share repurchase program that Hillman ha...
08-05 19:33
Hillman Solns (NASDAQ:HLMN) raises FY2025 sales outlook from $1.495 billion-$1.575 billion to $1.535 billion-$1.575 billion vs $1.536 billion estimate.
08-05 19:32
Hillman Solutions (NASDAQ:HLMN) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 18.06 percent. This is a 6.25 percent increase over earnings of $0.16 per share from
08-05 19:31
Hillman Solutions Corp. (NASDAQ:HLMN) (the "Company" or "Hillman"), a leading provider of hardware products and merchandising solutions, announced that its Board of Directors has authorized an initial share repurchase
08-05 19:26